$1.05
$-0.03 (-2.78%)
End-of-day quote: 05/21/2024
NasdaqGM:ACRX
AcelRx Pharmaceuticals Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | NYSE | Outperform | $151.24 | $174.55 | 0.00% | 3 | $363.99B |
| SUPN | Supernus Pharmaceuticals | NasdaqGM | Outperform | $28.05 | $41.00 | 0.00% | 0 | $1.72B |
| ANIP | ANI Pharmaceuticals | NasdaqGM | Buy | $61.71 | $69.75 | 0.00% | 1 | $1.38B |
| IRWD | Ironwood Pharmaceuticals | NasdaqGS | Buy | $6.78 | $17.83 | 0.00% | 2 | $1.29B |
| COLL | Collegium Pharmaceutical | NasdaqGS | Outperform | $34.50 | $37.75 | 0.00% | 1 | $1.24B |
| PCRX | Pacira BioSciences | NasdaqGS | Outperform | $30.90 | $47.90 | 0.00% | 6 | $1.23B |
| HRTX | Heron Therapeutics | NasdaqCM | Buy | $3.44 | $5.63 | 0.00% | 0 | $442.92M |
| AQST | Aquestive Therapeutics | NasdaqGM | Buy | $3.18 | $6.33 | 0.00% | 0 | $307.71M |
| ZVRA | Zevra Therapeutics | NasdaqGS | Buy | $4.62 | $19.50 | 0.00% | 1 | $204.66M |
| DRRX | DURECT | NasdaqCM | Outperform | $1.29 | $6.75 | 0.00% | 2 | $33.21M |
| CPIX | Cumberland Pharmaceuticals | NasdaqGS | - | $2.03 | $8.50 | 0.00% | 0 | $24.38M |
| TRVN | Trevena | NasdaqCM | Outperform | $0.61 | $5.18 | 0.00% | 0 | $9.38M |
| ACOR | Acorda Therapeutics | NasdaqGS | - | $0.85 | $200.00 | 0.00% | 1 | $0.53M |
| BXRX | Baudax Bio | OTCPK | - | $0.01 | $24.00 | 0.00% | 0 | $0.53M |
| DMK | DMK Pharmaceuticals | NasdaqCM | - | $0.03 | $1.50 | 0.00% | 0 | $0.31M |
